Study of adverse pregnancy outcome risks following treatment of CMV with ganciclovir or valganciclovir

Researchers with access to the VigiBase database of adverse drug reactions have conducted a disproportionality analysis of adverse pregnancy outcomes to identify safety signals associated with ganciclovir or valganciclovir use in pregnancy. More information can be found here. The authors of the study have also provided ENTIS with a visual abstract of their study: Photo by Wengang Zhai on Unsplash

» Read more

Case report of elexacaftor, tezacaftor, ivacaftor combination in pregnancy

Researchers from the Sapienza University Working Group on Cystic Fibrosis in Pregnancy have published a case report on the outcome of pregnancy in a woman treated with elexacaftor, tezacaftor, ivacaftor combination during the second and third trimester of pregnancy (following discontinuation in the first trimester). More information available here. Photo by Mockup Graphics on Unsplash

» Read more

No association between leukotriene-receptor antagonist use in pregnancy and ADHD, ASD or Tourette Syndrome in the offspring

Researchers affiliated to the National Health Research Institutes in Taiwan have published a large population-based cohort study investigating the risk of ADHD, ASD or Tourette Syndrome following maternal leukotriene-receptor antagonists use in pregnancy. Further information is available here. Photo by Robina Weermeijer on Unsplash

» Read more

Neurodevelopmental outcome of children exposed to pravastatin in utero

Researchers from the Eunice Kennedy Shriver National Institute of Child Health and Human Development-Obstetrics Fetal Pharmacology Research Centers Network have conducted a long-term follow-up study to determine the impact pravastatin treatment in pregnant women at high risk of preeclampsia may have on child health, growth, and neurodevelopment. The results of this small study, although limited by the trial’s sample size […]

» Read more

ConcePTION Project: Communication toolkit launch – 15th March

Communication experts from the IMI ConcePTION project have produced a toolkit will allow organisations with limited resources to design communication campaigns to stimulate reporting of medicine use during pregnancy and breastfeeding to appropriate organisations. ENTIS members are invited to join the online launch of this toolkit on 15th March, 1500-1600 Central European Time (CET). For more information about the toolkit, […]

» Read more

Limited evidence of a link between acetaminophen (paracetamol) and autism or ADHD

FactCheck.org have published an article on the interpretation of the available evidence surrounding autism and ADHD risks in children exposed to acetaminophen (paracetamol) in utero. The article concludes that there is currently no strong evidence that acetaminophen use during pregnancy causes autism or ADHD in children, and that experts continue to recommend use of the drug during pregnancy when necessary […]

» Read more

Systematic review and meta-analysis of malformation risk following maternal metformin use in pregnancy

Researchers, including several ENTIS members and Swiss Teratology Information Service colleagues, have published a systematic review and meta-analysis of major congenital malformation risk after first-trimester exposure to metformin in women with PCOS and pre-gestational diabetes mellitus. More information can be found here. Photo by Mae Mu on Unsplash

» Read more

Study provides data on childhood infection risk following in utero anti-TNFα monoclonal antibody exposure

A collaboration of researchers from Shanghai Jiao Tong University, Fudan University and Aarhus University have published a population-based cohort study investigating infectious disease in the offspring of women with inflammatory bowel disease in pregnancy. The study also investigated infection risk among those with in utero exposed to anti-TNFα monoclonal antibody. More information can be found here.

» Read more
1 … 13 14 15 16 17 … 32